10 Stocks Beating Wall Street’s Bets

3. Clover Health Investments, Corp. (NASDAQ:CLOV)

Clover Health surged by 19.37 percent on Friday to close at $3.82 apiece as investors took heart from a “buy” recommendation from an investment firm.

In a market note, Zacks Research upgraded Clover Health Investments, Corp. (NASDAQ:CLOV) to “buy,” following an upward trend in earnings estimates—one of the most powerful forces impacting stock prices.”

“For the fiscal year ending December 2025, [Clover Health Investments, Corp. (NASDAQ:CLOV)] is expected to earn $0.10 per share, which is unchanged compared with the year-ago reported number. Analysts have been steadily raising their estimates for Clover Health Investments. Over the past three months, the Zacks Consensus Estimate for the company has increased 25 percent,” the note said.

Based on its historical reporting dates, Clover Health Investments, Corp. (NASDAQ:CLOV) is expected to release the results of its third quarter financial and operating highlights on November 6, 2025.